BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9180924)

  • 1. Loss of heterozygosity at loci on chromosome 4, a common genetic event during the spontaneous immortalization of mouse embryonic fibroblasts.
    Obata M; Lee GH; Kanda H; Kitagawa T; Ogawa K
    Mol Carcinog; 1997 May; 19(1):17-24. PubMed ID: 9180924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity at the proximal-mid part of mouse chromosome 4 defines two novel tumor suppressor gene loci in T-cell lymphomas.
    Meléndez B; Santos J; Fernández-Piqueras J
    Oncogene; 1999 Jul; 18(28):4166-9. PubMed ID: 10435599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.
    Takita J; Hayashi Y; Kohno T; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
    Cancer Res; 1997 Mar; 57(5):907-12. PubMed ID: 9041193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
    Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
    Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Most liver epithelial cell lines from C3B6F1 mice exhibit parentally-biased loss of heterozygosity at the Lci (Liver cell immortalization) locus on chromosome 4.
    Lee GH; Ogawa K; Nishimori H; Drinkwater NR
    Oncogene; 1995 Dec; 11(11):2281-7. PubMed ID: 8570178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.
    Farrell WE; Simpson DJ; Bicknell JE; Talbot AJ; Bates AS; Clayton RN
    Cancer Res; 1997 Jul; 57(13):2703-9. PubMed ID: 9205080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors.
    Kuerbitz SJ; Malandro J; Compitello N; Baylin SB; Graff JR
    Cell Growth Differ; 1999 Jan; 10(1):27-33. PubMed ID: 9950215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
    Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
    Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelotype analysis of 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
    Zhuang SM; Eklund LK; Cochran C; Rao GN; Wiseman RW; Söderkvist P
    Cancer Res; 1996 Jul; 56(14):3338-43. PubMed ID: 8764131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
    Grady B; Goharderakhshan R; Chang J; Ribeiro-Filho LA; Perinchery G; Franks J; Presti J; Carroll P; Dahiya R
    J Urol; 2001 Sep; 166(3):1088-92. PubMed ID: 11490304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats.
    Tanaka T; Iwasa Y; Kondo S; Hiai H; Toyokuni S
    Oncogene; 1999 Jun; 18(25):3793-7. PubMed ID: 10391689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
    Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors.
    Herzog CR; Wiseman RW; You M
    Cancer Res; 1994 Aug; 54(15):4007-10. PubMed ID: 8033131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Codeletion of the JUN proto-oncogene and the CDKN2A tumor-suppressor gene in HRAS-transformed rat embryo fibroblast cell lines.
    Zhou JN; Ljungdahl S; Röhme D; Levan G; Shoshan MC; Linder S
    Genes Chromosomes Cancer; 1997 Sep; 20(1):82-9. PubMed ID: 9290958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of a putative tumor suppressor locus after gamma-ray-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids.
    Mendonca MS; Fasching CL; Srivatsan ES; Stanbridge EJ; Redpath JL
    Radiat Res; 1995 Jul; 143(1):34-44. PubMed ID: 7597142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines.
    Igaki H; Sasaki H; Kishi T; Sakamoto H; Tachimori Y; Kato H; Watanabe H; Sugimura T; Terada M
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1090-5. PubMed ID: 8093026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
    Thompson PM; Maris JM; Hogarty MD; Seeger RC; Reynolds CP; Brodeur GM; White PS
    Cancer Res; 2001 Jan; 61(2):679-86. PubMed ID: 11212268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.